Clinical Trial Update: Post-menopausal Women Osteoporosis(Phase III) [Phase 3]

View source ↗

Summary

A Phase III trial for osteoporosis in postmenopausal women has completed, but no efficacy or safety results are provided in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Snippet

Sponsor: Hanlim Pharm. Co., Ltd. | Conditions: Postmenopausal Women Osteoporosis | Phase 3 | Status: COMPLETED